Menu
Back to User profile » Dr Tan Yang
Papers published by Dr Tan Yang:
Delivery Of miR-375 And Doxorubicin By Lipid-Coated Hollow Mesoporous Silica Nanoparticles To Overcome Multiple Drug Resistance In Hepatocellular Carcinoma [Corrigendum]
Xue H, Yu Z, Liu Y, Yuan W, Yang T, You J, He X, Lee RJ, Li L, Xu C
International Journal of Nanomedicine 2019, 14:8753-8754
Published Date: 6 November 2019
Delivery of miR-375 and doxorubicin hydrochloride by lipid-coated hollow mesoporous silica nanoparticles to overcome multiple drug resistance in hepatocellular carcinoma
Xue H, Yu Z, Liu Y, Yuan W, Yang T, You J, He X, Lee RJ, Li L, Xu C
International Journal of Nanomedicine 2017, 12:5271-5287
Published Date: 24 July 2017
Antitumor activity of a folate receptor-targeted immunoglobulin G-doxorubicin conjugate
Yang T, Xu L, Li B, Li W, Ma X, Fan L, Lee RJ, Xu C, Xiang G
International Journal of Nanomedicine 2017, 12:2505-2515
Published Date: 30 March 2017
Targeted delivery of chemically modified anti-miR-221 to hepatocellular carcinoma with negatively charged liposomes
Zhang W, Peng F, Zhou T, Huang Y, Zhang L, Ye P, Lu M, Yang G, Gai Y, Yang T, Ma X, Xiang G
International Journal of Nanomedicine 2015, 10:4825-4836
Published Date: 29 July 2015
A novel hydrolysis-resistant lipophilic folate derivative enables stable delivery of targeted liposomes in vivo
Huang Y, Yang T, Zhang W, Lu Y, Ye P, Yang G, Li B, Qi S, Liu Y, He X, Lee RJ, Xu C, Xiang G
International Journal of Nanomedicine 2014, 9:4581-4595
Published Date: 29 September 2014
Folate receptor-targeted liposomes enhanced the antitumor potency of imatinib through the combination of active targeting and molecular targeting
Ye P, Zhang W, Yang T, Lu Y, Lu M, Gai Y, Ma X, Xiang G
International Journal of Nanomedicine 2014, 9:2167-2178
Published Date: 7 May 2014